-+ 0.00%
-+ 0.00%
-+ 0.00%

Regencell Bioscience prices 985,222-share registered direct offering at $20.30 each

PUBT·05/19/2026 20:32:10
Listen to the news
Regencell Bioscience prices 985,222-share registered direct offering at $20.30 each
  • Regencell Bioscience entered a registered direct offering to sell 985,222 ordinary shares at USD 20.3 each.
  • Gross proceeds expected at about USD 20 million, led by a USD 19 million investment from a new fundamental institutional investor.
  • Closing expected on or about May 20, 2026, subject to customary conditions.
  • Univest Securities is acting as sole placement agent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regencell Bioscience Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-059056), on May 19, 2026, and is solely responsible for the information contained therein.